The U.S. Food and Drug Administration last month warned of serious blood problems linked to use of six diabetes drugs, including AstraZeneca PLC’s Farxiga and Janssen Pharmaceuticals Inc.’s... Read more
It has been reported widely that there is a great deal of “outsourcing” in manufacturing and technical support. But beyond the economic impact of sending jobs overseas, this practice could n... Read more
The state of Texas and two former AstraZeneca LP employees have filed suit against the pharmaceutical giant in a Texas state court, accusing the company of cheating the state’s Medicaid prog... Read more
The U.S. Food and Drug Administration (FDA) has launched an investigation into the safety of an AstraZeneca PLC diabetes drug after a recent study found that users of the medication were mor... Read more
AstraZeneca, facing declining revenues last year, sold the marketing rights to its over-the-counter (OTC) version of Nexium to Pfizer Inc. for $250 million. AstraZeneca will be in line for m... Read more
AstraZeneca has agreed to pay $2.5 million in a settlement with the State of Idaho over the cost of drugs for the state’s Medicaid program. The state bases its reimbursement rates to pharmac... Read more
AstraZeneca Plc. has settled almost all of the lawsuits that claimed its antipsychotic drug Seroquel causes diabetes in some users. AstraZeneca, the U.K.’s second-biggest drugmaker, will pay... Read more
AstraZeneca has agreed to pay $103 million to settle class-action claims arising out of the company inflating the wholesale price of cancer and asthma treatments. The first settlement includ... Read more
Utah’s Attorney General has filed suit against Johnson & Johnson and AstraZeneca for the illegal off-label marketing of anti-psychotic drugs. The suit, filed in a Utah state court last m... Read more
The U.S. Department of Justice has reached two settlements with pharmaceutical companies that will call for a total of more than $100 million in penalties under the False Claims Act and the... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.